Amgen is teaming up with researchers at MGH and the Broad Institute to find new targets in inflammatory bowel disease. Two European drug discovery centers and an Italian CRO have partnered to launch a drug screening facility. Also, a roundup of public-private partnership activity, headlined by a funding initiative in New York.